Impact of Treatment Induced Premature Menopause on Quality of Life
This study has been completed.
Information provided by (Responsible Party):
First received: September 12, 2005
Last updated: December 12, 2012
Last verified: December 2012
To understand the impact of treatment induced menopause on quality of life and sexuality following blood and marrow transplantation.
|Study Design:||Time Perspective: Prospective|
|Official Title:||Impact of Treatment Induced Premature Menopause on Quality of Life Following Blood and Marrow Transplantation|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Stanford University:
Primary Outcome Measures:
- Quality of life [ Time Frame: 1 year ] [ Designated as safety issue: No ]To describe the impact of premature menopause on sexuality and quality of life.
- Sexuality [ Time Frame: 1 year ] [ Designated as safety issue: No ]To describe the impact of premature menopause on sexuality and quality of life.
|Study Start Date:||November 2003|
|Study Completion Date:||September 2010|
|Primary Completion Date:||September 2010 (Final data collection date for primary outcome measure)|
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00185718
|United States, California|
|Stanford University School of Medicine|
|Stanford, California, United States, 94305|
Sponsors and Collaborators
|Principal Investigator:||Karl G. Blume||Stanford University|